Developer docs
API playgroundTry for free, no card

Search company profiles

Pentavere

Full company profile

uuid00076yp

Namestring
Pentavere
Legal namestring
Pentavere Research Group Inc.
Websiteurl
pentavere.ai
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Pentavere Research Group Inc., founded in 2016 and headquartered in Toronto, is a healthcare AI company that builds and commercializes DARWEN AI, a proprietary clinical natural language processing engine designed to extract structured data from unstructured electronic health records (EHRs), including consult notes, radiology reports, pathology reports, and clinical narratives. The technology combines linguistic rules-based algorithms, transformer-based models, deep learning, and machine-learned inferred rules, and is trained on a proprietary corpus of over 100,000 patients with an average of 50 clinical notes per patient; DARWEN supports contextual disambiguation such as negation, hypothesis, and experiencer, and has been validated in peer-reviewed publications reporting accuracy above 90% on complex clinical features across oncology, tuberculosis, dermatology, and rare disease cohorts.

DARWEN powers a portfolio of specialized applications rather than a single product, including a Breast Cancer Data and Analytics Platform (7,019 patients, 141 data elements), a Cancer Staging Clinician Co-pilot developed with Sunnybrook, a Radiation-Related Late Toxicities detection module, a Heart Failure Patient Identification & Optimization Program, and rare disease real-world evidence (RWE) services such as the Takeda hereditary angioedema program. The company also offers Clinical Decision Support, RWE & Advanced Analytics, and Data Enrichment and Structuring services.

Pentavere operates as a B2B enterprise with a direct field-sales motion, selling to two primary customer segments: global pharmaceutical companies (it states it works with 6 of the top-10 largest pharma, with disclosed logos including Takeda, Janssen/Johnson & Johnson, Roche, Amgen, and UCB) and healthcare providers/cancer centers (including University Health Network/Princess Margaret, Sunnybrook, Unity Health, St. Michael's, Juravinski, and St. Boniface). Revenue is generated through subscription/recurring enterprise agreements and project-based services, pricing is quote-based and not publicly disclosed, and the company holds ISO 9001, ISO/IEC 27001, and SOC 2 certifications. Pentavere is a subsidiary of HEALWELL AI Inc. (TSX: AIDX), consolidated within its AI & Data Science Business Unit alongside Khure Health, and the company has won the Prix Galien USA 2024 Best Digital Health Startup award.

Short descriptiontext

Pentavere is a Toronto-based healthcare AI company that builds DARWEN AI, a proprietary clinical NLP engine which extracts structured data from unstructured EHR text to identify eligible patients and generate real-world evidence for global pharmaceutical companies and major hospital systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical natural language processing, healthcare AI platform, electronic health records analytics, real-world evidence generation, patient identification analytics
Industry3 codes
PRIMARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPAEAHAG
Generative AI & LLM Solutions Services (RAG, Agents, Copilots)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare AI / Clinical Natural Language Processing Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare AI/SaaS Services
TypeSubscription Recurring
Description

Pentavere generates revenue through enterprise agreements with healthcare systems, hospitals, and life sciences companies for AI-powered data extraction, patient identification, and real-world evidence generation services. The company operates as a B2B SaaS and services model, providing technology solutions to healthcare providers and pharmaceutical companies.

pentavere.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1DARWEN™ AI
Description

Pentavere's proprietary AI engine that identifies patients eligible for approved medications or interventions, accelerates discovery from clinical text, and unlocks real-world evidence from unstructured hospital electronic medical records.

pentavere.ai
Core offering1 text field

Pentavere builds and operates DARWEN™ AI, a proprietary clinical natural language processing engine that extracts structured patient and clinical data from unstructured electronic health record text. The company sells enterprise AI solutions — patient identification programs (e.g., heart failure), real-world evidence analytics, clinical decision support, and data enrichment services — to healthcare providers, hospital systems, and global pharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • NLP achieved accuracy of 96% for simple features, 93% for moderate complexity features, and 91% for complex features in TB clinic study (Journal of Medical Internet Research)
+4 more records
Product overview1 text field

Pentavere is a Patient Identification Company that has built DARWEN™ AI, a best-in-class AI engine to identify patients eligible for approved medications or interventions to improve outcomes. The company's offering centers on a unified AI platform that combines NLP, machine learning, and deep learning (including transformer-based models) to extract structured clinical data from unstructured hospital EHRs. The core DARWEN™ AI platform powers multiple specialized applications including patient identification programs (Heart Failure), clinical decision support tools (Cancer Staging Clinician Co-pilot), disease detection capabilities (Radiation-Related Toxicities), and real-world evidence generation services. The company also delivers complementary services including Clinical Decision Support (CDS), Real-World Evidence & Advanced Analytics, and Data Enrichment and Structuring Services. Pentavere operates as a subsidiary of HEALWELL AI within the AI & Data Science Business Unit alongside Khure Health.

Product and service9 records
1DARWEN™ AI
CategoryCore Product / AI Platform
Description

Pentavere's flagship AI engine that identifies patients eligible for approved medications or interventions by processing unstructured hospital EHR data. Combines NLP (linguistic rules-based algorithms, deep learning, and transformer-based models) with machine learning to extract, structure, and analyze clinical data at scale, enabling real-world evidence generation and clinical decision support.

2Heart Failure Patient Identification & Optimization Program
CategoryPatient Identification Program
Description

A specialized DARWEN AI-powered program that identifies heart failure patients who may be eligible for different medications or interventions to improve patient outcomes.

3Cancer Staging Clinician Co-pilot System
CategoryClinical Decision Support
Description

An AI-powered clinical decision support system developed with Sunnybrook that assists clinicians in improving cancer staging accuracy.

4Radiation-Related Toxicities Detection
CategoryDisease Detection Capability
Description

DARWEN AI capability that identifies radiation-related late toxicities including dysphagia, fibrosis, osteoradionecrosis, and trismus from head and neck cancer patient EHRs.

5Breast Cancer Data and Analytics Platform
CategoryHealthcare Data & Analytics Platform
Description

An automated longitudinal prospective data and analytics platform for breast cancer at regional cancer centers, combining data warehousing with NLP to deliver integrated, timely, high-quality data for learning health system activities.

6Rare Disease Real-World Evidence Analysis
CategoryReal-World Evidence Service
Description

DARWEN AI-powered service that analyzes clinical data to generate real-world evidence for rare disease patient populations, exemplified by hereditary angioedema (HAE) and idiopathic angioedema research.

7Clinical Decision Support (CDS)
CategoryClinical Decision Support Service
Description

AI-enabled tools integrated with EMR systems that analyze patient data to identify patients at risk of rare or complex diseases, surface guideline-based insights, support risk stratification, and highlight potential clinical trial eligibility.

8Real-World Evidence & Advanced Analytics
CategoryAdvanced Analytics Service
Description

Data extraction, NLP, and analytics platforms that transform structured and unstructured clinical data, identify patient cohorts, generate population-level insights, support REB-approved studies, and produce real-world evidence outputs for quality improvement and health system reporting.

9Data Enrichment and Structuring Services
CategoryData Services
Description

Solutions that convert raw or unstructured PHI into structured formats, perform data standardization and validation, and support clinical operations and research analytics.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-28
Description

Pentavere (along with Intrahealth and OceanMD, other WELL Health subsidiaries) was selected for Canada Health Infoway's 2025 Vendor Innovation Program. The project focuses on improving healthcare data interoperability through AI-powered tools and standardized FHIR-based systems, to be deployed in live clinical environments across five Canadian provinces.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-06
Description

Partnership to support rare disease real-world evidence analysis for patients living with hereditary angioedema (HAE). Pentavere's AI technology extracts clinical data to analyze patient outcomes, treatment patterns, and healthcare utilization for this rare condition.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-21
Description

Partnership to demonstrate that Pentavere's AI-powered clinician co-pilot system can improve cancer staging. The collaboration resulted in a peer-reviewed publication demonstrating the technology's effectiveness in supporting clinical decision-making.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-11
Description

Pentavere was awarded the Takeda Canada Innovation Challenge to collaborate on a proof-of-concept AI project focused on rare disease care. The partnership involves using Pentavere's DARWEN AI technology to generate real-world evidence for rare disease patients across Canada, with dedicated funding and access to Takeda's expertise and international network.

Strategic tierCoreTypeOthers
Description

Pentavere Research Group Inc. is a subsidiary of HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care. HEALWELL consolidates Pentavere and Khure Health under its AI & Data Science business unit.

6Journal of Clinical Oncology
Strategic tierMinorTypeGTM or Marketing Partner
Description

Academic publication partnership validating DARWEN AI technology for automated data extraction from EHRs. Published studies demonstrate technology accuracy and clinical applicability for generating real-world evidence.

pentavere.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing collaboration for extracting and analyzing lung cancer patient data using DARWEN AI. The partnership enables querying of clinical data to understand treatment patterns, real-world outcomes, and support research initiatives.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Datavant connects and de-identifies real-world patient data across providers and life sciences customers for research and analytics. It is a peer in the health data connectivity and RWE value chain that Pentavere serves through DARWEN.

2Tempus Labs
TypeDirect peer
Description

Tempus applies AI to clinical and molecular data to enable precision medicine, with direct applications in oncology patient identification and RWE generation. It competes with Pentavere in AI-driven EHR data structuring for pharma and providers.

TypeDirect peer
Description

Verana Health curates real-world clinical data from specialty EHR networks to support pharma research and physician decision-making. It is directly comparable to Pentavere's DARWEN-based approach of extracting structured insights from unstructured EHR data for life sciences customers.

TypeDirect peer
Description

TriNetX operates a global health research network that leverages EHR data for clinical trial feasibility and real-world studies. It overlaps with Pentavere's patient identification and clinical research use cases for pharma customers.

TypeEmerging player
Description

Owkin applies AI to clinical and omics data to support pharma R&D and patient stratification, with a growing focus on oncology. It is an emerging player competing for similar pharma AI and real-world data budgets as Pentavere.

6nference
TypeDirect peer
Description

nference applies NLP and AI to biomedical and clinical text to generate real-world evidence for pharma and providers. Its technology stack and target customer base closely mirror Pentavere's DARWEN AI engine and life sciences partnerships.

TypeBroad incumbent
Description

IQVIA is the largest contract research and real-world evidence company, offering technology platforms for clinical data extraction and RWE generation serving the same top-10 pharma customer base as Pentavere. It is a broad incumbent covering the same enterprise pharma and provider use cases at much greater scale.

TypeDirect peer
Description

Flatiron Health builds EHR-derived real-world datasets, primarily in oncology, and partners with pharma for RWE and clinical research. It is the closest direct peer to Pentavere, working with leading cancer centers and pharma on structured data extraction from unstructured clinical text.

TypeDirect peer
Description

Aetion provides a real-world evidence analytics platform used by top pharma companies and regulators for treatment effectiveness and safety studies. It overlaps with Pentavere's RWE offering for pharma customers and competes for similar enterprise contracts.

TypeBroad incumbent
Description

Medidata is a leading clinical trial technology platform offering EDC, RWE, and analytics for life sciences sponsors. As a broad incumbent in clinical research informatics, it overlaps with the EDC and RWE use cases Pentavere targets with DARWEN.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pentavere

Healthcare AI / Clinical Natural Language Processing Softwarepentavere.ai

Pentavere is a Toronto-based healthcare AI company that builds DARWEN AI, a proprietary clinical NLP engine which extracts structured data from unstructured EHR text to identify eligible patients and generate real-world evidence for global pharmaceutical companies and major hospital systems.

What Pentavere does

Pentavere Research Group Inc., founded in 2016 and headquartered in Toronto, is a healthcare AI company that builds and commercializes DARWEN AI, a proprietary clinical natural language processing engine designed to extract structured data from unstructured electronic health records (EHRs), including consult notes, radiology reports, pathology reports, and clinical narratives. The technology combines linguistic rules-based algorithms, transformer-based models, deep learning, and machine-learned inferred rules, and is trained on a proprietary corpus of over 100,000 patients with an average of 50 clinical notes per patient; DARWEN supports contextual disambiguation such as negation, hypothesis, and experiencer, and has been validated in peer-reviewed publications reporting accuracy above 90% on complex clinical features across oncology, tuberculosis, dermatology, and rare disease cohorts.

DARWEN powers a portfolio of specialized applications rather than a single product, including a Breast Cancer Data and Analytics Platform (7,019 patients, 141 data elements), a Cancer Staging Clinician Co-pilot developed with Sunnybrook, a Radiation-Related Late Toxicities detection module, a Heart Failure Patient Identification & Optimization Program, and rare disease real-world evidence (RWE) services such as the Takeda hereditary angioedema program. The company also offers Clinical Decision Support, RWE & Advanced Analytics, and Data Enrichment and Structuring services.

Pentavere operates as a B2B enterprise with a direct field-sales motion, selling to two primary customer segments: global pharmaceutical companies (it states it works with 6 of the top-10 largest pharma, with disclosed logos including Takeda, Janssen/Johnson & Johnson, Roche, Amgen, and UCB) and healthcare providers/cancer centers (including University Health Network/Princess Margaret, Sunnybrook, Unity Health, St. Michael's, Juravinski, and St. Boniface). Revenue is generated through subscription/recurring enterprise agreements and project-based services, pricing is quote-based and not publicly disclosed, and the company holds ISO 9001, ISO/IEC 27001, and SOC 2 certifications. Pentavere is a subsidiary of HEALWELL AI Inc. (TSX: AIDX), consolidated within its AI & Data Science Business Unit alongside Khure Health, and the company has won the Prix Galien USA 2024 Best Digital Health Startup award.

Pentavere firmographics

Firmographics
Name
Pentavere
Legal name
Pentavere Research Group Inc.
Website
https://pentavere.ai
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Pentavere is a Toronto-based healthcare AI company that builds DARWEN AI, a proprietary clinical NLP engine which extracts structured data from unstructured EHR text to identify eligible patients and generate real-world evidence for global pharmaceutical companies and major hospital systems.
Ownership category
akta.pro rank

Pentavere industry classification

Industry
Product category
Healthcare AI / Clinical Natural Language Processing Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPAEAHAG
Generative AI & LLM Solutions Services (RAG, Agents, Copilots)

Keywords

  • Clinical natural language processing
  • Healthcare AI platform
  • Electronic health records analytics
  • Real-world evidence generation
  • Patient identification analytics

Where Pentavere is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Pentavere business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Healthcare AI/SaaS Services: Pentavere generates revenue through enterprise agreements with healthcare systems, hospitals, and life sciences companies for AI-powered data extraction, patient identification, and real-world evidence generation services. The company operates as a B2B SaaS and services model, providing technology solutions to healthcare providers and pharmaceutical companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Pentavere product offering

Product offering

Core offering

Pentavere builds and operates DARWEN™ AI, a proprietary clinical natural language processing engine that extracts structured patient and clinical data from unstructured electronic health record text. The company sells enterprise AI solutions — patient identification programs (e.g., heart failure), real-world evidence analytics, clinical decision support, and data enrichment services — to healthcare providers, hospital systems, and global pharmaceutical companies.

Product overview

Pentavere is a Patient Identification Company that has built DARWEN™ AI, a best-in-class AI engine to identify patients eligible for approved medications or interventions to improve outcomes. The company's offering centers on a unified AI platform that combines NLP, machine learning, and deep learning (including transformer-based models) to extract structured clinical data from unstructured hospital EHRs. The core DARWEN™ AI platform powers multiple specialized applications including patient identification programs (Heart Failure), clinical decision support tools (Cancer Staging Clinician Co-pilot), disease detection capabilities (Radiation-Related Toxicities), and real-world evidence generation services. The company also delivers complementary services including Clinical Decision Support (CDS), Real-World Evidence & Advanced Analytics, and Data Enrichment and Structuring Services. Pentavere operates as a subsidiary of HEALWELL AI within the AI & Data Science Business Unit alongside Khure Health.

Differentiator

Problem solved

Functional benefit

Brands

  • DARWEN™ AI: Pentavere's proprietary AI engine that identifies patients eligible for approved medications or interventions, accelerates discovery from clinical text, and unlocks real-world evidence from unstructured hospital electronic medical records.

Products and services

  • DARWEN™ AI Pentavere's flagship AI engine that identifies patients eligible for approved medications or interventions by processing unstructured hospital EHR data. Combines NLP (linguistic rules-based algorithms, deep learning, and transformer-based models) with machine learning to extract, structure, and analyze clinical data at scale, enabling real-world evidence generation and clinical decision support.
  • Heart Failure Patient Identification & Optimization Program A specialized DARWEN AI-powered program that identifies heart failure patients who may be eligible for different medications or interventions to improve patient outcomes.
  • Cancer Staging Clinician Co-pilot System An AI-powered clinical decision support system developed with Sunnybrook that assists clinicians in improving cancer staging accuracy.
  • Radiation-Related Toxicities Detection DARWEN AI capability that identifies radiation-related late toxicities including dysphagia, fibrosis, osteoradionecrosis, and trismus from head and neck cancer patient EHRs.
  • Breast Cancer Data and Analytics Platform An automated longitudinal prospective data and analytics platform for breast cancer at regional cancer centers, combining data warehousing with NLP to deliver integrated, timely, high-quality data for learning health system activities.
  • Rare Disease Real-World Evidence Analysis DARWEN AI-powered service that analyzes clinical data to generate real-world evidence for rare disease patient populations, exemplified by hereditary angioedema (HAE) and idiopathic angioedema research.
  • Clinical Decision Support (CDS) AI-enabled tools integrated with EMR systems that analyze patient data to identify patients at risk of rare or complex diseases, surface guideline-based insights, support risk stratification, and highlight potential clinical trial eligibility.
  • Real-World Evidence & Advanced Analytics Data extraction, NLP, and analytics platforms that transform structured and unstructured clinical data, identify patient cohorts, generate population-level insights, support REB-approved studies, and produce real-world evidence outputs for quality improvement and health system reporting.
  • Data Enrichment and Structuring Services Solutions that convert raw or unstructured PHI into structured formats, perform data standardization and validation, and support clinical operations and research analytics.

Quantifiable outcome

  • NLP achieved accuracy of 96% for simple features, 93% for moderate complexity features, and 91% for complex features in TB clinic study (Journal of Medical Internet Research)
  • +4 more outcomes

Companies that use Pentavere

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Pentavere technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Pentavere partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Canada Health InfowaycoreStrategic or Co-development Partner · 28 May 2025Pentavere (along with Intrahealth and OceanMD, other WELL Health subsidiaries) was selected for Canada Health Infoway's 2025 Vendor Innovation Program. The project focuses on improving healthcare data interoperability through AI-powered tools and standardized FHIR-based systems, to be deployed in live clinical environments across five Canadian provinces.
  • Takeda CanadacoreStrategic or Co-development Partner · 6 June 2024Partnership to support rare disease real-world evidence analysis for patients living with hereditary angioedema (HAE). Pentavere's AI technology extracts clinical data to analyze patient outcomes, treatment patterns, and healthcare utilization for this rare condition.
  • Sunnybrook Health Sciences CentrecoreStrategic or Co-development Partner · 21 May 2024Partnership to demonstrate that Pentavere's AI-powered clinician co-pilot system can improve cancer staging. The collaboration resulted in a peer-reviewed publication demonstrating the technology's effectiveness in supporting clinical decision-making.
  • Takeda CanadacoreStrategic or Co-development Partner · 11 May 2022Pentavere was awarded the Takeda Canada Innovation Challenge to collaborate on a proof-of-concept AI project focused on rare disease care. The partnership involves using Pentavere's DARWEN AI technology to generate real-world evidence for rare disease patients across Canada, with dedicated funding and access to Takeda's expertise and international network.
  • HEALWELL AIcoreOthersPentavere Research Group Inc. is a subsidiary of HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care. HEALWELL consolidates Pentavere and Khure Health under its AI & Data Science business unit.
  • Journal of Clinical OncologyminorGTM or Marketing PartnerAcademic publication partnership validating DARWEN AI technology for automated data extraction from EHRs. Published studies demonstrate technology accuracy and clinical applicability for generating real-world evidence.
  • Princess Margaret Cancer Centre (UHN)coreStrategic or Co-development PartnerLong-standing collaboration for extracting and analyzing lung cancer patient data using DARWEN AI. The partnership enables querying of clinical data to understand treatment patterns, real-world outcomes, and support research initiatives.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Pentavere competitors and assessment

Company assessment

Direct peers

  • Datavant: Datavant connects and de-identifies real-world patient data across providers and life sciences customers for research and analytics. It is a peer in the health data connectivity and RWE value chain that Pentavere serves through DARWEN.
  • Tempus Labs: Tempus applies AI to clinical and molecular data to enable precision medicine, with direct applications in oncology patient identification and RWE generation. It competes with Pentavere in AI-driven EHR data structuring for pharma and providers.
  • Verana Health: Verana Health curates real-world clinical data from specialty EHR networks to support pharma research and physician decision-making. It is directly comparable to Pentavere's DARWEN-based approach of extracting structured insights from unstructured EHR data for life sciences customers.
  • TriNetX: TriNetX operates a global health research network that leverages EHR data for clinical trial feasibility and real-world studies. It overlaps with Pentavere's patient identification and clinical research use cases for pharma customers.
  • nference: nference applies NLP and AI to biomedical and clinical text to generate real-world evidence for pharma and providers. Its technology stack and target customer base closely mirror Pentavere's DARWEN AI engine and life sciences partnerships.
  • Flatiron Health: Flatiron Health builds EHR-derived real-world datasets, primarily in oncology, and partners with pharma for RWE and clinical research. It is the closest direct peer to Pentavere, working with leading cancer centers and pharma on structured data extraction from unstructured clinical text.
  • Aetion: Aetion provides a real-world evidence analytics platform used by top pharma companies and regulators for treatment effectiveness and safety studies. It overlaps with Pentavere's RWE offering for pharma customers and competes for similar enterprise contracts.

Emerging players

  • Owkin: Owkin applies AI to clinical and omics data to support pharma R&D and patient stratification, with a growing focus on oncology. It is an emerging player competing for similar pharma AI and real-world data budgets as Pentavere.

Broad incumbents

  • IQVIA: IQVIA is the largest contract research and real-world evidence company, offering technology platforms for clinical data extraction and RWE generation serving the same top-10 pharma customer base as Pentavere. It is a broad incumbent covering the same enterprise pharma and provider use cases at much greater scale.
  • Medidata (Dassault Systèmes): Medidata is a leading clinical trial technology platform offering EDC, RWE, and analytics for life sciences sponsors. As a broad incumbent in clinical research informatics, it overlaps with the EDC and RWE use cases Pentavere targets with DARWEN.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Pentavere social profiles

Digital presence

Pentavere compliance and trust

Trust signal

Compliance3 records

Pentavere financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pentavere leadership team

Management profile

Number of profiles

Profiles6 records

Pentavere funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pentavere M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pentavere

What does Pentavere do?

Pentavere builds and operates DARWEN™ AI, a proprietary clinical natural language processing engine that extracts structured patient and clinical data from unstructured electronic health record text. The company sells enterprise AI solutions — patient identification programs (e.g., heart failure), real-world evidence analytics, clinical decision support, and data enrichment services — to healthcare providers, hospital systems, and global pharmaceutical companies.

Is Pentavere a public or private company?

Pentavere is a private company. It is classified as corporate owned and is currently operating.

When was Pentavere founded?

Pentavere was founded in 2016. It employs 11 to 50 people.

Where is Pentavere based?

Pentavere is headquartered in Toronto, Canada, in the North America region.

How does Pentavere make money?

One revenue line is on record: healthcare AI/SaaS Services.

Who are Pentavere's main competitors?

Direct peers on record are Datavant, Tempus Labs, Verana Health, TriNetX, nference, Flatiron Health and Aetion. Owkin is listed as an emerging player. Broad incumbents are IQVIA and Medidata (Dassault Systèmes).

Does Pentavere have an API?

No public API is recorded for Pentavere.

What industry is Pentavere in?

Pentavere's product category is Healthcare AI / Clinical Natural Language Processing Software. Its primary akta.pro industry code is HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs), with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileHEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences InnovationHEALWELL AI announced that its subsidiary, Pentavere Research Group, has been nominated for the 2026 International Prix Galien Award in the Best Startup category. This nomination follows Pentavere's 2024 win at the Prix Galien USA Award and places DARWEN™ AI among innovations from major global healthcare companies like AstraZeneca and Pfizer. The recognition serves as independent validation of HEALWELL's strategy to integrate DARWEN™ across its healthcare technology ecosystem, including Orion Health.YahooHEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences InnovationHEALWELL AI Inc.'s subsidiary, Pentavere Research Group, has been nominated for the 2026 International Prix Galien Award in the Best Startup category, following its previous win at the 2024 Prix Galien USA. This nomination places the developer of the DARWEN™ AI platform among global healthcare innovators from major pharmaceutical and biotechnology firms. The recognition serves as independent validation of HEALWELL's strategy to integrate DARWEN™ across its healthcare technology ecosystem to scale AI-powered clinical intelligence globally.The Globe and MailWELL Health Reports Record Revenue, Record Adjusted EBITDA, and Record Adjusted Net Income in Q3-2025 Driven by Strong Performance in Core Canadian BusinessesWELL Health Technologies Corp. reported record Q3-2025 financial results with quarterly revenue of $364.6 million, up 56% year-over-year from $234.1 million, driven by strong performance in both Canadian and U.S. patient services and the inclusion of HEALWELL results. Adjusted EBITDA reached $59.9 million, a 296% increase year-over-year, while Adjusted Net Income was $41.0 million ($0.16 per share) compared to $4.1 million ($0.02 per share) in Q3-2024. The company also announced its WELLSTAR subsidiary secured a $62 million Series B financing at a $535 million post-money valuation, and HEALWELL completed strategic transactions including acquiring full ownership of Pentavere Research Group and forming a clinical research joint venture.AInvestHEALWELL AI: Accelerating to Dominance in AI-Driven Healthcare Through Strategic IntegrationHEALWELL AI completed its acquisition of Pentavere Research Group, paying $13.98 million in shares, and reported a 208% year-over-year revenue increase to $14.1 million in Q1-2025. The company also acquired Orion Health, which brings $100 million in annual SaaS revenue, and holds 30 master services agreements with pharmaceutical firms.GlobeNewswireHEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical ConferencesHEALWELL AI's subsidiaries Khure Health and Pentavere Research Group will present AI work at medical conferences in May 2024. Khure presents at the National Kidney Foundation Spring Clinical Meetings, while Pentavere presents at the Canadian Retina Society, American Head & Neck Society, and AMIA Clinical Informatics conferences.YahooHow AI is Transforming Healthcare and Saving LivesHEALWELL AI, a physician-led healthcare technology company, acquired Pentavere and Intrahealth Systems, and secured $29.5 million in funding. The AI healthcare market is projected to grow from $20.9 billion in 2024 to $148.4 billion by 2029. The company is pursuing additional acquisitions, having evaluated over 100 opportunities.GlobeNewswireHEALWELL AI Provides Corporate Update Highlighting its Growth and Value Creation Strategy and Recent Commercial SuccessesHEALWELL AI provided a corporate update on its growth strategy, highlighting commercial successes with KHURE and Pentavere. The company raised about $29.5 million, acquired Pentavere, and has 17 services agreements with pharma companies. It plans to launch new AI initiatives in dermatology and other specializations in 2024.GlobeNewswireHEALWELL AI Provides Corporate Update Highlighting its Growth and Value Creation Strategy and Recent Commercial SuccessesHEALWELL AI provided a corporate update on its growth strategy, highlighting commercial successes and acquisition plans. The company raised about $29.5 million, acquired Pentavere, and has 17 pharma services agreements. It plans to launch new AI initiatives in dermatology and other specializations in 2024.Investing.comHealwell AI finalizes acquisition of Pentavere, eyes growth in healthcare AI By Investing.comHealwell AI completed its acquisition of Pentavere Research Group for CAD 5.9 million, gaining a majority stake. The deal integrates Pentavere's DARWEN technology to enhance data abstraction from medical records, with additional CAD 1.2 million invested on December 1. The acquisition aims to strengthen Healwell's healthcare AI capabilities and partnerships.Canadian Healthcare TechnologyHEALWELL to attain majority ownership of PentavereHEALWELL AI plans to acquire a majority ownership stake in Pentavere Research Group for $15 million, including $1.75 million cash and $4.16 million in AIDX stock. The deal adds revenue, partnerships, and access to five pharma customers, with HEALWELL to appoint a majority of Pentavere's board seats.